SWP
GSK icon

Stratos Wealth Partners’s GSK GSK Stock Holding History

Stratos Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$711K Sell
12,884
-9,508
-42% -$515K 0.01% 930
2025
Q4 		$1.1M Buy
22,392
+2,401
+12% +$112K 0.01% 740
2025
Q3 		$863K Buy
19,991
+7,210
+56% +$282K 0.01% 805
2025
Q2 		$491K Sell
12,781
-1,722
-12% -$65.8K 0.01% 939
2025
Q1 		$562K Sell
14,503
-1,504
-9% -$55.1K 0.01% 839
2024
Q4 		$541K Sell
16,007
-2,111
-12% -$76K 0.01% 905
2024
Q3 		$741K Sell
18,118
-2,043
-10% -$83.6K 0.01% 787
2024
Q2 		$776K Sell
20,161
-2,614
-11% -$110K 0.01% 747
2024
Q1 		$976K Sell
22,775
-675
-3% -$27.8K 0.02% 659
2023
Q4 		$869K Buy
23,450
+1,992
+9% +$71.5K 0.02% 675
2023
Q3 		$778K Buy
21,458
+2,536
+13% +$90K 0.02% 653
2023
Q2 		$674K Buy
18,922
+4,752
+34% +$170K 0.02% 663
2023
Q1 		$504K Sell
14,170
-4,669
-25% -$163K 0.01% 699
2022
Q4 		$662K Sell
18,839
-1,687
-8% -$56.2K 0.02% 630
2022
Q3 		$604K Buy
20,526
+1,225
+6% +$46.4K 0.02% 621
2022
Q2 		$1.05M Buy
19,301
+278
+1% +$15.3K 0.03% 498
2022
Q1 		$1.04M Sell
19,023
-865
-4% -$47K 0.02% 539
2021
Q4 		$1.1M Buy
19,888
+4,079
+26% +$212K 0.02% 527
2021
Q3 		$755K Buy
15,809
+1,164
+8% +$58.5K 0.02% 611
2021
Q2 		$729K Buy
14,645
+326
+2% +$15.7K 0.02% 646
2021
Q1 		$639K Sell
14,319
-260
-2% -$11.8K 0.02% 631
2020
Q4 		$671K Sell
14,579
-1,367
-9% -$62.8K 0.02% 578
2020
Q3 		$750K Buy
15,946
+644
+4% +$32.3K 0.02% 492
2020
Q2 		$780K Sell
15,302
-196
-1% -$10.1K 0.03% 439
2020
Q1 		$734K Buy
15,498
+2,282
+17% +$122K 0.03% 402
2019
Q4 		$776K Buy
13,216
+288
+2% +$16K 0.03% 462
2019
Q3 		$690K Sell
12,928
-666
-5% -$34.3K 0.03% 478
2019
Q2 		$680K Sell
13,594
-814
-6% -$40.8K 0.03% 475
2019
Q1 		$753K Buy
14,408
+2,542
+21% +$127K 0.03% 439
2018
Q4 		$567K Buy
11,866
+87
+0.7% +$4.29K 0.03% 471
2018
Q3 		$591K Buy
11,779
+309
+3% +$15.7K 0.03% 479
2018
Q2 		$578K Sell
11,470
-2,603
-18% -$131K 0.03% 528
2018
Q1 		$687K Buy
14,073
+2,068
+17% +$96.3K 0.03% 452
2017
Q4 		$532K Sell
12,005
-3,090
-20% -$143K 0.02% 511
2017
Q3 		$766K Sell
15,095
-2,867
-16% -$145K 0.04% 392
2017
Q2 		$968K Buy
17,962
+1,185
+7% +$63.2K 0.05% 301
2017
Q1 		$884K Buy
16,777
+7,267
+76% +$369K 0.05% 304
2016
Q4 		$458K Sell
9,510
-2,941
-24% -$145K 0.03% 407
2016
Q3 		$671K Buy
12,451
+2,385
+24% +$131K 0.05% 300
2016
Q2 		$545K Buy
10,066
+1,215
+14% +$64K 0.04% 320
2016
Q1 		$449K Sell
8,851
-11,902
-57% -$593K 0.04% 314
2015
Q4 		$1.05M Sell
20,753
-5,375
-21% -$274K 0.09% 173
2015
Q3 		$1.26M Sell
26,128
-3,394
-11% -$177K 0.16% 123
2015
Q2 		$1.54M Buy
29,522
+6,192
+27% +$349K 0.2% 108
2015
Q1 		$1.34M Buy
23,330
+5,574
+31% +$320K 0.16% 134
2014
Q4 		$949K Buy
17,756
+1,652
+10% +$92.4K 0.17% 137
2014
Q3 		$926K Buy
16,104
+1,319
+9% +$80.9K 0.22% 107
2014
Q2 		$990K Buy
+14,785
New +$1M 0.33% 89

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stratos Wealth Partners's GSK Position: Q1 2026 in Review

Stratos Wealth Partners reduced its GSK (GSK) stake by 42% in Q1 2026, selling an estimated $515K and leaving 12,884 shares worth $711K. The position accounts for 0.01% of the portfolio, ranked #930.

Stratos Wealth Partners first reported a position in GSK in Q2 2014 and has held it in 48 quarters since. The position peaked at $1.54M in Q2 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Stratos Wealth Partners held 12,884 shares of GSK worth $711K as of Q1 2026.
  • Stratos Wealth Partners sold 9,508 GSK shares in Q1 2026, an estimated $515K.
  • GSK made up 0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #930 holding.
  • Stratos Wealth Partners first reported a position in GSK in Q2 2014 and has held it in 48 quarters since.
  • Stratos Wealth Partners's GSK position peaked at $1.54M in Q2 2015.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.